Decision

Advertising investigations: January 2023

Decisions made by the MHRA following investigations into complaints about advertising for licensed medicines.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 4 May 2023

Documents

Third parties offering medicines treatment services

MS Word Document, 21.8 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Promotion of hair-loss treatments by Hims UK Limited – January 2023

MS Word Document, 20.4 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Contact [email protected] if you have concerns with the advertising of medicines or write to:

Advertising Standards Unit,
10 South Colonnade,
Canary Wharf,
London E14 4PU

Alternatively, contact the pharmaceutical self-regulatory bodies, the Proprietary Association of Great Britain (PAGB) for advertising for over the counter medicines, or the Prescription Medicines Code of Practice Authority (PMCPA) for advertisements to health professionals for prescription medicines.

See the Blue Guide for guidance on how medicines should be promoted or advertised in the UK.

Published 4 May 2023